Document:

EX-10.3

 

Exhibit 10.3

INDEMNITY AGREEMENT

BY AND BETWEEN

WEBMD CORPORATION

AND

WEBMD HEALTH CORP.

DATED AS OF [ ], 2005

 

 

Table of Contents

	 	 	 	 	 	 	 
	 	 	 	 	Page
	SECTION 1.	 	Indemnification.
	 	 	2	 
	 	 	 
	 	 	 	 
	SECTION 2.	 	Substitution.
	 	 	3	 
	 	 	 
	 	 	 	 
	SECTION 3.	 	Notice and Payment of Claim.
	 	 	3	 
	 	 	 
	 	 	 	 
	SECTION 4.	 	Dispute Resolution.
	 	 	4	 
	 	 	 
	 	 	 	 
	SECTION 5.	 	Cooperation.
	 	 	4	 
	 	 	 
	 	 	 	 
	SECTION 6.	 	Assignment.
	 	 	5	 
	 	 	 
	 	 	 	 
	SECTION 7.	 	Notices.
	 	 	5	 
	 	 	 
	 	 	 	 
	SECTION 8.	 	Further Assurances.
	 	 	5	 
	 	 	 
	 	 	 	 
	SECTION 9.	 	Governing Law.
	 	 	5	 
	 	 	 
	 	 	 	 
	SECTION 10.	 	Entire Agreement.
	 	 	5	 
	 	 	 
	 	 	 	 
	SECTION 11.	 	Counterparts.
	 	 	6	 
	 	 	 
	 	 	 	 
	SECTION 12.	 	Severability.
	 	 	6	 
	 	 	 
	 	 	 	 
	SECTION 13.	 	Successors and Assigns.
	 	 	6	 
	 	 	 
	 	 	 	 
	SECTION 14.	 	Headings.
	 	 	6	 

2

 

INDEMNITY AGREEMENT

          THIS INDEMNITY AGREEMENT (this “Agreement”) is made and entered into as of
[___], 2005 by and between WebMD Corporation, a Delaware corporation (“Parent”)
on behalf of itself and the other Parent Entities (as defined below), and WebMD Health Corp., a
Delaware corporation (the “Company”), on behalf of itself and the other Company Entities
(as defined below).

RECITALS

     WHEREAS, the Company is a wholly owned subsidiary of Parent;

     WHEREAS, pursuant to the transactions contemplated by the registration statement of the
Company on Form S-1 (File No. 333-124832) filed with the Securities and Exchange Commission on May
12, 2005, as the same may be amended from time to time (the “Registration Statement”), the
Company intends to offer [___] shares of Company’s Class A common stock in an initial
public offering (the “Offering”);

     WHEREAS, in consideration of the foregoing and as a condition to the willingness of the
parties to proceed with the Offering, the Company has agreed to indemnify Parent, and Parent has
agreed to indemnify the Company, as more fully described below.

     For purposes of this Agreement the following terms shall have the following meanings:

     “Company Entities” means: (i) prior to the consummation of the Offering, the entities
included in the WebMD Health Segment, and (ii) after the consummation of the Offering, the Company
and its subsidiaries.

     “Parent Entities” means: (i) prior to the consummation of the Offering, the Parent and
its subsidiaries (other than subsidiaries included in the WebMD Health Segment), and (ii) after the
consummation of the Offering, Parent and its subsidiaries (other than the Company).

     “Third Party Claims” means any claim, action, suit, arbitration, inquiry, proceeding
or investigation by or before any Governmental Authority or any claim, audit, demand or assessment
by any party other than a Parent Entity or a Company Entity.

     “WebMD Health Segment” means Parent’s WebMD Health segment (formerly the Portal
Services segment) prior to the consummation of the Offering.

     NOW, THEREFORE, in consideration of the mutual covenants set forth in this Agreement and other
good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the
parties hereto agree as follows:

AGREEMENT

1

 

     SECTION 1. Indemnification. (a) The Company agrees to indemnify and hold harmless
Parent against any and all claims, losses, damages, liabilities, costs and expenses, joint or
several (including reasonable attorneys’ fees and costs of investigation), to which Parent may
become subject insofar as such claims, losses, damages, liabilities, costs and expenses (or actions
in respect thereof) arise from or are based on any Third Party Claims in respect of: (i) the
operations, before or after the consummation of the Offering, of the WebMD Health Segment prior to
the Offering and the operations of the business of the Company and its subsidiaries after the
Offering (collectively, the “Company Business”); provided, however, that Parent shall not
be indemnified hereunder for liabilities arising from its own intentional misconduct or gross
negligence; or (ii) the business or activities of any business or entity acquired by the WebMD
Health Segment prior to the Offering (“WebMD Acquired Entities”), including, without limitation,
any alleged act or omission of the respective employees, officers and directors of such WebMD
Acquired Entities prior to their acquisition, or (iii) any material untrue statements or omissions
in any prospectus or any related registration statement filed with the Securities and Exchange
Commission relating to the Offering, provided, however, that Parent shall not be
indemnified hereunder for liabilities arising from any such material untrue statement or omission
which is contained in or pertains to information relating solely to Parent.

     (b) Parent agrees to indemnify and hold harmless the Company against any and all claims,
losses, damages, liabilities, costs and expenses, joint or several (including reasonable attorneys’
fees and costs of investigation), to which the Company may become subject insofar as such claims,
losses, damages, liabilities, costs and expenses (or actions in respect thereof) arise from or are
based on before or after the consummation of the Offering: (i) the operations of the business of
Parent and its subsidiaries (excluding the WebMD Health Segment ) prior to the Offering and the
operations of the business of Parent and its subsidiaries after the Offering (excluding the Company
and its subsidiaries), (ii) Merrill Lynch Fundamental Growth Fund, Inc.,et al. v. McKesson HBOC,
Inc., et al., Case No. 405792 or any other case, controversy or proceeding arising out of or based
upon the allegations of such case or any predecessor case, including, without limitation,
any appeal or related proceeding, (iii) the business or activities of any business or entity
acquired by Parent and its subsidiaries (excluding the WebMD Health Segment) prior to the Offering
(“Parent Acquired Entities”), including, without limitation, any alleged act or omission of the
respective employees, officers and directors of such Parent Acquired Entities prior to their
acquisition, or (iv) any material untrue statements or omissions in any prospectus or any related
registration statement filed with the Securities and Exchange Commission relating to the Offering
(A) relating to descriptions of the Parent Business, or (B) relating to statements specifically
identified as being made by Parent.

     (c) The Company agrees to indemnify and hold harmless Parent against any and all claims,
losses, damages, liabilities, costs and expenses, joint or several (including reasonable attorneys’
fees and costs of investigation), to which Parent may become subject insofar as such claims,
losses, damages, liabilities, costs and expenses (or actions in respect thereof) arise from or are
based on guarantees or undertakings made by Parent to third parties in respect of liabilities or
obligations of the Company or its subsidiaries.

     (d) Notwithstanding anything to the contrary herein, this Agreement shall not alter the rights
and obligations under the agreements listed on Schedule A hereto or any

2

 

agreements entered into after the date hereof between any Parent Entity and any Company Entity
and no indemnity is given under this Agreement by the Company or Parent with respect to any such
agreements.

     SECTION 2. Substitution. (a) With respect to any litigation, proceeding or
investigation by or before any court or governmental agency or body which may be commenced or
threatened against Parent after the date hereof which arises out of or is based upon the future
business or operations of the Company, but not of Parent, at Parent’s option, the Company and
Parent shall use their commercially reasonable efforts to have the Company substituted in the place
of and for Parent and to have Parent removed as a party as promptly as is reasonably practicable.
Pending such substitution, and in cases where such substitution cannot be effected, the Company
shall promptly assume and direct the defense, prosecution and/or settlement of the claims involved,
employing for this purpose counsel satisfactory to Parent, and shall pay all expenses related
thereto. To the extent that any such expenses are paid by Parent, the Company shall promptly
reimburse Parent therefor.

     (b) With respect to any litigation, proceeding or investigation by or before any court or
governmental agency or body which may be commenced or threatened against the Company after the date
hereof which arises out of or is based upon the future business or operations of Parent, but not of
the Company, at the Company’s option, the Company and Parent shall use their commercially
reasonable efforts to have Parent substituted in the place of and for the Company and to have the
Company removed as a party as promptly as is reasonably practicable. Pending such substitution,
and in cases where such substitution cannot be effected, Parent shall promptly assume and direct
the defense, prosecution and/or settlement of the claims involved, employing for this purpose
counsel satisfactory to the Company, and shall pay all expenses related thereto. To the extent
that any such expenses are paid by the Company, Parent shall promptly reimburse the Company
therefor.

     SECTION 3. Notice and Payment of Claim. If either party entitled to indemnification
hereunder (an “Indemnified Party”) is threatened in writing with any claim, or any claim is
presented in writing to, or any action or proceeding formally commenced against, an Indemnified
Party which may give rise to the right of indemnification hereunder, the Indemnified Party will
promptly give written notice thereof to the other party (the “Indemnifying Party”),
provided that any delay by the Indemnified Party in so notifying the Indemnifying Party shall not
relieve the Indemnifying Party of any liability to the Indemnified Party hereunder except to the
extent the Indemnifying Party is materially and adversely prejudiced by such delay. The
Indemnifying Party, by delivery of written notice to the Indemnified Party within 30 days of
receipt of notice of claim to indemnity from the Indemnified Party, may elect to contest such
claim, action or proceeding at the Indemnifying Party’s expense and by counsel of its own choosing.
An Indemnifying Party will not, without the prior written consent of the Indemnified Party (which
consent shall not be unreasonably withheld), settle or compromise or consent to the entry of any
judgment with respect to any pending or threatened claim, action, suit or proceeding in respect of
which indemnification may be sought hereunder (whether or not the Indemnified Party is an actual or
potential party to such claim or action) unless such settlement, compromise or consent includes an
unconditional release of the Indemnified Party from all liability arising out of such claim,
action, suit or proceeding.

3

 

     SECTION 4. Dispute Resolution. (a) In an effort to resolve informally and amicably
any claim or controversy arising out of or related to this Agreement or the breach, termination,
enforcement, interpretation or validity thereof, each party shall notify the other of any
differences or dispute hereunder that requires resolution. Parent and the Company shall each
designate an executive officer to investigate, discuss and seek to settle the matter between them.
If the two are unable to settle the matter within 30 days after such notification, the matter shall
be submitted to an independent director of Parent who is not also a director or employee of the
Company and an independent director of the Company who is not also a director or employee of Parent
for consideration. If settlement cannot be reached through their efforts within an additional 30
days, or such longer time period as they shall agree upon, either party may initiate final and
binding arbitration, in accordance with Paragraph (b) of this Section 4 to resolve such matter,
which the parties agree are the sole and exclusive procedures for any such dispute. All offers,
promises, conduct and statements, whether oral or written, made in the course of the settlement
discussions contemplated by this Paragraph (a) by any of the parties, their agents, employees,
experts and attorneys are confidential, privileged and inadmissible for any purpose, including
impeachment, in any arbitration or other proceeding involving the parties, provided that evidence
that is otherwise admissible or discoverable shall not be rendered inadmissible or non-discoverable
as a result of its use in the mediation.

     (b) Any dispute, claim or controversy arising out of or relating to this Agreement or the
breach, termination, enforcement, interpretation or validity thereof, including the determination
of the scope or applicability of this agreement to arbitrate, shall be determined by arbitration in
New York, New York before one arbitrator. The arbitration shall be administered by JAMS pursuant
to its Comprehensive Arbitration Rules and Procedures. Judgment on the award may be entered in any
court having jurisdiction. This clause shall not preclude parties from seeking provisional
remedies in aid of arbitration from a court of appropriate jurisdiction. The parties shall share
the costs of the arbitrator and other costs of the arbitration equally and each party shall be
responsible for its own costs and expenses relating to the arbitration, including for fees and
expenses of its attorneys and other professionals that it retains. The arbitrator will have no
authority to award any special, punitive, exemplary, consequential, incidental or indirect losses
or damages and no authority to award a party any amounts for the costs and expenses of the
arbitration or for fees and expenses of attorneys and other professionals retained by a party.

     SECTION 5. Cooperation. So long as any books, records and files retained by Parent or
the Company relating to the business operations or assets of the Company remain in existence and
available, Parent and the Company shall have the right upon prior notice to inspect and copy the
same at any time during business hours for any proper purpose. Neither Parent nor the Company
shall destroy or permit the destruction of (without first having offered to deliver to the other)
any such books, records and files for the time period during which they would be required to retain
such books, records or files by applicable law. Parent and the Company shall cooperate with one
another in a timely manner in any administrative or judicial proceeding involving any matter
affecting the potential liability of either Parent or the Company hereunder or with respect to any
governmental authority. Such cooperation shall include, without limitation, making available to
the other party, during normal business hours, all books, records and information, officers and
employees (without substantial interruption of employment)

4

 

necessary or useful in connection with any inquiry, audit, investigation or dispute, any
litigation or any other matter requiring any such books, records, information, officers or
employees for any reasonable business purpose. The party requesting or otherwise entitled to any
books, records, information, officers, or employees pursuant to this Section shall bear all
reasonable out-of-pocket costs and expenses (except reimbursement of salaries, employee benefits
and general overhead) incurred in connection with providing such books, records, information,
officers or employees.

     SECTION 6. Assignment. Neither party shall assign or transfer any of its rights under
this Agreement without the prior written consent of the other party.

     SECTION 7. Notices. All notices, requests, demands and other communications provided
for by this Agreement shall be in writing (including telecopier or similar writing) and shall be
deemed to have been given at the time when mailed in any general or branch office of the United
States Postal Service, enclosed in a registered or certified postpaid envelope, or sent by Federal
Express or other similar overnight courier service, addressed to the address of the parties stated
below or to such changed address as such party may have fixed by notice or, if given by telecopier,
when such telecopy is transmitted and the appropriate answerback is received.

If to Parent:

WebMD Corporation

[                    ]

If to the Company:

WebMD Health Corp.

[                    ]

     SECTION 8. Further Assurances. Parent and the Company shall execute, acknowledge and
deliver or cause to be executed, acknowledged and delivered such instruments and take such other
action as may be necessary or advisable to carry out their obligations under this Agreement and
under any exhibit, document or other instruments delivered pursuant hereto.

     SECTION 9. Governing Law. This Agreement shall be governed by and construed in
accordance with the laws of the State of New York.

     SECTION 10. Entire Agreement. This Agreement, together with any other agreements
between the parties, constitutes the entire understanding between the parties and supersedes all
proposals, commitments, writings, negotiations and understandings, oral and written, and all other
communications between the parties relating to the subject matter of this Agreement. This
Agreement may not be amended or otherwise modified except in writing duly executed by all of the
parties. A waiver by any party of any breach or violation of this Agreement shall not be deemed or
construed as a waiver of any subsequent breach or violation thereof.

5

 

     SECTION 11. Counterparts. This Agreement may be executed in several counterparts,
each of which shall be deemed an original, but all of which together shall constitute one and the
same document.

     SECTION 12. Severability. Should any part, term or condition hereof be declared
illegal or unenforceable or in conflict with any other law, the validity of the remaining portions
or provisions of this Agreement shall not be affected thereby, and the illegal or unenforceable
portions of this Agreement shall be and hereby are redrafted to conform with applicable law, while
leaving the remaining portions of this Agreement intact.

     SECTION 13. No Third Party Beneficiaries; Successors and Assigns. This Agreement is
solely for the benefit of the Parent Entities and the Company Entities and their respective
successors and assigns. Nothing expressed or mentioned in this Agreement is intended or shall be
construed to give any other person any legal or equitable right, remedy or claim under or in
respect of this Agreement, or any provisions herein contained, this Agreement and all conditions
and provisions hereof being intended to be and being for the sole and exclusive benefit of the
Company Entities and the Parent Entities and their respective successors and legal representatives,
and for the benefit of no other person,

     SECTION 14. Headings. Section headings are for convenience only and do not control or
affect the meaning or interpretation of any terms or provisions of this Agreement.

6

 

     IN WITNESS WHEREOF, the parties have executed this Agreement on the date first above written.

	 	 	 	 	 
	 	WEBMD CORPORATION on behalf of itself and the other Parent Entities

 	 
	 	By:  	
 	 
	 	 	Name:  	 	 
	 	 	Title:  	 	 
	 

	 	 	 	 	 
	 	WEBMD HEALTH CORP. on behalf of itself and the other Company Entities

 	 
	 	By:  	
 	 
	 	 	Name:  	 	 
	 	 	Title:  	 	 

7

 

	 	 	 	 	 

SCHEDULE A

	1.	 	The Intellectual Property License Agreement dated the date
hereof between Parent and the Company
	 
	2.	 	The Tax Sharing Agreement dated the date hereof between Parent
and the Company
	 
	3.	 	The Services Agreement dated the date hereof between Parent and
the Company
	 
	4.	 	The Registration Rights Agreement dated the date hereof between
Parent and the Company

8EX-10.4

 

Exhibit 10.4

TRADEMARK LICENSE AGREEMENT

          This TRADEMARK LICENSE AGREEMENT (this “Agreement”) is made and effective as
of September___, 2005 (the “Effective Date”) by and between WebMD Inc., a Georgia
Corporation and a wholly-owned subsidiary of WebMD Health Corp. (“Licensor”), and WebMD
Corporation (d/b/a Emdeon Corporation), a Delaware Corporation
(“Licensee”) (each a “party” and
collectively, the “parties”).

RECITALS

          WHEREAS, Licensor is the owner of all right, title and interest in and to the trademarks and
trade names set forth on Schedule 1 and all graphical representations related thereto (the
“Licensed Marks”);

          WHEREAS, Licensee has previously used the Licensed Marks in the operation of its business;

          WHEREAS, Licensee desires to obtain the right to use during a transitional period the Licensed
Marks solely in connection with certain products and services Licensee provides; and

          WHEREAS, Licensor desires to grant to Licensee, and Licensee desires to obtain, a license to
use the Licensed Marks in connection with said products and services subject to the terms and
conditions of this Agreement.

          NOW, THEREFORE, in consideration of the mutual covenants and agreements contained herein and
for other good and valuable consideration, the receipt and sufficiency of which are hereby
acknowledged, the parties hereto hereby agree as follows:

ARTICLE 1

LICENSE GRANT

          1.1 License Grant. Subject to the terms and conditions set forth herein, Licensor
hereby grants to Licensee, and Licensee hereby accepts from Licensor, a paid-up, royalty-free,
worldwide, non-transferable, non-exclusive right and license to use the Licensed Marks solely on
the Licensee’s products or in connection with the operation of the Licensee’s business, and in
accordance with the terms and conditions set forth in Section 1.4. Licensor may sublicense the
Licensed Marks only to its authorized distributors, subcontractors and resellers solely for the
purpose of using the Licensed Marks in connection with advertising and promotion of the Licensee’s
business and the Licensee’s products in accordance with Section 1.3.

          1.2 Limitation on Grant. Except as expressly set forth in this Agreement, no other
right or license is granted to Licensee by implication or otherwise with respect to the Licensed
Marks, including, but not limited to, the right to use any intellectual property owned by Licensor
other than the Licensed Marks.

 

 

          1.3 Form of Use. Licensee shall use the Licensed Marks only in the same form and
manner as Licensee’s use of the Licensed Marks immediately prior to the Effective Date. In the
event that Licensee desires to use the Licensed Marks in some other form or manner, Licensee shall
first obtain Licensor’s prior written consent, which consent shall not be unreasonably withheld or
delayed.

          1.4 Winding Down. Licensee shall use commercially reasonable efforts to wind down and
to cease its use of the Licensed Marks as soon as commercially practicable, including, but not
limited to, removing the Licensed Marks from its signs, letterhead, advertisements and promotional
materials.

ARTICLE 2

OWNERSHIP

          2.1 Ownership. Licensee acknowledges and agrees that Licensor is the owner of all
right, title, and interest in and to the Licensed Marks, and all such right, title, and interest
shall remain with Licensor. Licensee shall not otherwise contest, dispute, or challenge Licensor’s
right, title, and interest in and to the Licensed Marks.

          2.2 Goodwill. All goodwill and improved reputation generated by Licensee’s use of the
Licensed Marks shall inure to the benefit of Licensor. Licensee shall not by any act or omission
use the Licensed Marks in any manner that tarnishes, degrades, disparages or reflects adversely on
Licensor or Licensor’s business or reputation.

          2.3 Quality Control. In order to preserve the inherent value of the Licensed Marks,
Licensee agrees to use reasonable efforts to ensure that the quality of the services Licensee
provides shall continue to be at least equal to the standards prevailing in the operation of
Licensor’s and Licensee’s business as of the Effective Date. Licensee will comply, in all material
respects, with Licensor’s trademark usage guidelines, in the form previously provided by Licensor
to Licensee or in such other form as may be provided by Licensor to Licensee from time to time.

          2.4 Compliance With Laws. Licensee agrees that the business operated by it in
connection with the Licensed Marks shall comply with all laws, rules, regulations and requirements
of any governmental body as may be applicable to the operation, advertising and promotion of
Licensee’s business.

          2.5 Notification of Infringement. Each party shall immediately notify the other party
and provide to the other party all relevant background facts upon becoming aware of (i) any
registrations of, or applications for registration of, marks that do or may conflict with the
Licensed Marks, and (ii) any infringements, imitations, dilutions, illegal use or misuse of the
Licensed Marks.

ARTICLE 3

REPRESENTATIONS AND WARRANTIES

          3.1 Mutual Representations. Each party hereby represents and warrants to the other
party as follows:

 

 

     (a) Due Authorization. The execution, delivery and performance of this
Agreement by such party have been duly authorized by all necessary action on the part of
such party.

     (b) Due Execution. This Agreement has been duly executed and delivered by such
party and, with due authorization, execution and delivery by the other party, constitutes a
legal, valid and binding obligation of such party, enforceable against such party in
accordance with its terms.

     (c) No Conflict. Such party’s execution, delivery and performance of this
Agreement do not: (i) violate, conflict with or result in the breach of, any provision of
the partnership agreement, charter or by-laws (or similar organizational documents) of such
party; (ii) conflict with or violate any law or governmental order applicable to such party
or any of its assets, properties or businesses; or (iii) conflict with, result in any breach
of, constitute a default (or event which with the giving of notice or lapse of time, or
both, would become a default) under, require any consent under, or give to others any rights
of termination, amendment, acceleration, suspension, revocation or cancellation of any
contract, agreement, lease, sublease, license, permit, franchise or other instrument or
arrangement to which it is a party.

          3.2 Indemnity. Licensee shall defend, indemnify and hold harmless Licensor from and
against any claims, actions, demands, suits, causes of action, losses, damages, liabilities,
judgments, costs and expenses (including reasonable attorneys’ fees) arising out of any breach of
Licensee’s representations and warranties set forth in Section 3.1. Licensor shall defend,
indemnify and hold harmless Licensee from and against any claims, actions, demands, suits, causes
of action, losses, damages, liabilities, judgments, costs and expenses (including reasonable
attorneys’ fees) arising out of any breach of Licensor’s representations and warranties set forth
in Section 3.1.

ARTICLE 4

TERM

          4.1 Term. Unless earlier terminated, this Agreement shall have an initial term
beginning on the Effective Date and ending on the fifth anniversary of the Effective Date (the
“Initial Term”). Thereafter, this Agreement shall automatically renew for successive 12-month
renewal terms unless either party notifies the other party of such party’s intention not to renew
this Agreement, in writing, not less than 90 days prior to the end of the then current term.
Notwithstanding any of the foregoing, during the Initial Term, Licensor may terminate this
Agreement if Licensee materially breaches this Agreement, and such material breach continues
unremedied for a period of 180 days after written notice thereof. Following the Initial Term,
Licensor may terminate this Agreement at any time and for any reason, upon 90 days written notice
to Licensee.

          4.2 Rights On Termination. Upon expiration or termination of this Agreement, all
rights granted to Licensee under this Agreement with respect to the Licensed Marks shall cease, and
Licensee shall discontinue immediately the use of the Licensed Marks.

 

 

ARTICLE 5

MISCELLANEOUS

          5.1 Assignment. This Agreement shall be binding upon and inure to the benefit of the
parties hereto and their respective successors and permitted assigns. Neither party may assign,
delegate or otherwise transfer this Agreement or any of its rights or obligations hereunder without
the prior written consent of the other party. No assignment by either party permitted hereunder
shall relieve the applicable party of its obligations under this Agreement. Any assignment by
either party in accordance with the terms of this Agreement shall be pursuant to a written
assignment agreement in which the assignee expressly assumes the assigning party’s rights and
obligations hereunder.

          5.2 Independent Contractor. Neither party shall have, or shall represent that it has,
any power, right or authority to bind the other party to any obligation or liability, or to assume
or create any obligation or liability on behalf of the other party.

          5.3 Notices. All notices, requests, claims, demands and other communications
hereunder shall be in writing and shall be given or made (and shall be deemed to have been duly
given or made upon receipt) by delivery in person, by overnight courier service (with signature
required), by facsimile, or by registered or certified mail (postage prepaid, return receipt
requested) to the respective parties at the following addresses:

	 	 	 
	If to Licensor:

	 	If to Licensee:
	WebMD Inc. c/o WebMD Health Corp.

	 	WebMD Corporation
	Attn: General Counsel

	 	Attn: General Counsel
	111 Eighth Avenue

	 	669 River Drive, Center 2
	New York, NY 10011

	 	Elmwood, NJ 07407
	Tel: (212) 624-3700

	 	Tel: (201) 703-3400
	Fax: (212) 624-3747

	 	Fax: (201) 703-3401

          5.4 Governing Law. This Agreement shall be governed by, and construed in accordance
with, the laws of the State of New York without giving effect to the conflicts of law principles
thereof.

          5.5 Arbitration.

     (a) In an effort to resolve informally and amicably any claim or controversy arising
out of or related to this Agreement or the breach, termination, enforcement, interpretation
or validity thereof, each party shall notify the other of any differences or dispute
hereunder that requires resolution. Licensee and the Licensor shall each designate an
executive officer to investigate, discuss and seek to settle the matter between them. If
the two are unable to settle the matter within 30 days after such notification, the matter
shall be submitted to an independent director of Licensee who is not also a director or
employee of the Licensor and an independent director of the Licensor who is not also a
director or employee of Licensee for consideration. If settlement cannot be reached through
their efforts within an additional 30 days, or such longer time period as they shall agree
upon, either party may initiate final and binding arbitration, in accordance with Paragraph
(b) of this Section 5.5 to resolve such matter, which the

 

 

parties agree are the sole and exclusive procedures for any such dispute. All offers,
promises, conduct and statements, whether oral or written, made in the course of the
settlement discussions contemplated by this Paragraph (a) by any of the parties, their
agents, employees, experts and attorneys are confidential, privileged and inadmissible for
any purpose, including impeachment, in any arbitration or other proceeding involving the
parties, provided that evidence that is otherwise admissible or discoverable shall not be
rendered inadmissible or non-discoverable as a result of its use in the mediation.

     (b) Any dispute, claim or controversy arising out of or relating to this Agreement or
the breach, termination, enforcement, interpretation or validity thereof, including the
determination of the scope or applicability of this agreement to arbitrate, shall be
determined by arbitration in New York, New York before one arbitrator. The arbitration
shall be administered by JAMS pursuant to its Comprehensive Arbitration Rules and
Procedures. Judgment on the award may be entered in any court having jurisdiction. This
clause shall not preclude parties from seeking provisional remedies in aid of arbitration
from a court of appropriate jurisdiction. The parties shall share the costs of the
arbitrator and other costs of the arbitration equally and each party shall be responsible
for its own costs and expenses relating to the arbitration, including for fees and expenses
of its attorneys and other professionals that it retains. The arbitrator will have no
authority to award any special, punitive, exemplary, consequential, incidental or indirect
losses or damages and no authority to award a party any amounts for the costs and expenses
of the arbitration or for fees and expenses of attorneys and other professionals retained by
a party.

          5.6 Amendment. This Agreement may not be amended or modified except by an instrument
in writing signed by all parties hereto.

          5.7 No Waiver. The failure of either party to enforce at any time for any period the
provisions of or any rights deriving from this Agreement shall not be construed to be a waiver of
such provisions or rights or the right of such party thereafter to enforce such provisions, and no
waiver shall be binding unless executed in writing by all parties hereto.

          5.8 Severability. If any term or other provision of this Agreement is invalid,
illegal or incapable of being enforced by any law or public policy, all other terms and provisions
of this Agreement shall nevertheless remain in full force and effect so long as the economic or
legal substance of the transactions contemplated hereby is not affected in any manner materially
adverse to any party. Upon such determination that any term or other provision is invalid, illegal
or incapable of being enforced, the parties hereto shall negotiate in good faith to modify this
Agreement so as to effect the original intent of the parties as closely as possible in an
acceptable manner in order that the transactions contemplated hereby are consummated as originally
contemplated to the greatest extent possible.

          5.9 Headings. The descriptive headings contained in this Agreement are for
convenience of reference only and shall not affect in any way the meaning or interpretation of this
Agreement.

 

 

          5.10 Counterparts. This Agreement may be executed in one or more counterparts, each
of which when executed shall be deemed to be an original instrument and all of which taken together
shall constitute one and the same agreement.

          5.11 Entire Agreement. This Agreement constitutes the entire agreement of the parties
with respect to the subject matter hereof and supersedes all prior agreements and undertakings,
both written and oral, between the parties with respect to such subject matter.

          5.12 No Third-Party Beneficiaries. Nothing in this Agreement, either express or
implied, is intended to or shall confer upon any third party any legal or equitable right, benefit
or remedy of any nature whatsoever under or by reason of this Agreement.

          IN WITNESS WHEREOF, each party has caused this Agreement to be executed as of the Effective
Date by its duly authorized partner or officer.

	 	 	 	 	 	 	 
	LICENSOR:	 	LICENSEE:
	 
	 	 	 	 	 	 
	WebMD Inc.	 	WebMD Corporation (d/b/a Emdeon Corporation)
	 
	 	 	 	 	 	 
	By:

	 	 
	 	By:
	 	 
	 

	 	 
	 	 	 	 
	Name:	 	Name:
	Title:	 	Title:

 

 

SCHEDULE 1

LICENSED MARKS

	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Licensed Mark	 	Country	 	Status	 	Reg. No.	 	 	Renewal Date	 	 	Class No.	 
	WEBMD
	 	Georgia (States)	 	Docketed	 	 	 	 	 	 	 	 	 	 	 	 
	WEBMD
	 	Bangladesh	 	Pending	 	 	 	 	 	 	 	 	 	 	16	 
	WEBMD
	 	Italy	 	Pending	 	 	 	 	 	 	 	 	 	 	 	 
	WEBMD
	 	Malaysia	 	Pending	 	 	 	 	 	 	 	 	 	Nat’l 44	 
	WEBMD
	 	Pakistan	 	Pending	 	 	 	 	 	 	 	 	 	 	16	 
	WEBMD
	 	Argentina	 	Registered	 	 	1.852.362	 	 	 	11/20/2011	 	 	 	42	 
	WEBMD
	 	Australia	 	Registered	 	 	795825	 	 	 	5/31/2009	 	 	 	42	 
	WEBMD
	 	Austria	 	Registered	 	 	188 184	 	 	 	5/31/2010	 	 	 	38	 
	WEBMD
	 	Benelux	 	Registered	 	 	659.069	 	 	 	6/4/2009	 	 	 	35, 41, 42	 
	WEBMD
	 	Bolivia	 	Registered	 	 	79677-C	 	 	 	7/3/2010	 	 	 	42	 
	WEBMD
	 	Bulgaria	 	Registered	 	 	37355	 	 	 	6/3/2009	 	 	 	42	 
	WEBMD
	 	Canada	 	Registered	 	TMA586,679	 	 	 	8/6/2018	 	 	 	N/A	 
	WEBMD
	 	Chile	 	Registered	 	 	551648	 	 	 	10/29/2009	 	 	 	42	 
	WEBMD
	 	China	 	Registered	 	 	14999962	 	 	 	12/27/2010	 	 	 	42	 
	WEBMD
	 	Colombia	 	Registered	 	 	226041	 	 	 	4/13/2010	 	 	 	42	 
	WEBMD
	 	CTM	 	Registered	 	 	1197441	 	 	 	6/30/2009	 	 	 	35, 36	 
	WEBMD
	 	Croatia	 	Registered	 	 	Z990562	 	 	 	6/4/2009	 	 	 	42	 
	WEBMD
	 	Cuba	 	Registered	 	 	130299	 	 	 	6/7/2009	 	 	 	38	 
	WEBMD
	 	Czech Republic	 	Registered	 	 	232599	 	 	 	6/7/2009	 	 	 	42	 
	WEBMD
	 	Dominican Republic	 	Registered	 	 	106599	 	 	 	8/30/2019	 	 	Nat’l 70	 
	WEBMD
	 	Ecuador	 	Registered	 	 	1-1354-00	 	 	 	6/28/2010	 	 	 	42	 
	WEBMD
	 	El Salvador	 	Registered	 	1 Book 128	 	 	 	4/5/2011	 	 	 	42	 
	WEBMD
	 	Finland	 	Registered	 	 	221372	 	 	 	8/31/2011	 	 	 	35, 38, 41, 42	 
	WEBMD
	 	France	 	Registered	 	 	99 795 924	 	 	 	6/30/2009	 	 	 	35, 36, 38, 41, 42	 
	WEBMD
	 	Germany	 	Registered	 	 	399 31 516	 	 	 	6/30/2009	 	 	 	38	 
	WEBMD
	 	Greece	 	Registered	 	 	140 766	 	 	 	6/7/2009	 	 	 	38, 42	 
	WEBMD
	 	Guatemala	 	Registered	 	 	102933	 	 	 	2/27/2010	 	 	 	42	 
	WEBMD
	 	Hungary	 	Registered	 	 	160 908	 	 	 	5/31/2009	 	 	 	42	 
	WEBMD
	 	Iceland	 	Registered	 	 	8191999	 	 	 	8/4/2009	 	 	 	42	 
	WEBMD
	 	Indonesia	 	Registered	 	 	461231	 	 	 	7/28/2009	 	 	 	42	 
	WEBMD
	 	Iran	 	Registered	 	 	88520	 	 	 	12/29/2009	 	 	 	35	 
	WEBMD
	 	Ireland	 	Registered	 	 	215372	 	 	 	5/30/2009	 	 	 	42	 
	WEBMD
	 	Israel	 	Registered	 	 	128284	 	 	 	6/5/2006	 	 	 	42	 
	WEBMD
	 	Japan	 	Registered	 	 	4477813	 	 	 	5/25/2011	 	 	 	42	 

 

 

	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	Licensed Mark	 	Country	 	Status	 	Reg. No.	 	 	Renewal Date	 	 	Class No.	 
	WEBMD
	 	Lebanon	 	Registered	 	 	79921	 	 	 	6/4/2014	 	 	 	42	 
	WEBMD
	 	Lithuania	 	Registered	 	 	41025	 	 	 	5/31/2009	 	 	 	42	 
	WEBMD
	 	Mexico	 	Registered	 	 	626,855	 	 	 	6/7/2009	 	 	 	42	 
	WEBMD
	 	Morocco	 	Registered	 	 	69914	 	 	 	6/4/2019	 	 	 	42	 
	WEBMD
	 	New Zealand	 	Registered	 	 	612976	 	 	 	4/20/2007	 	 	 	38	 
	WEBMD
	 	New Zealand	 	Registered	 	 	310430	 	 	 	12/7/2005	 	 	 	42	 
	WEBMD
	 	New Zealand	 	Registered	 	 	612975	 	 	 	4/20/2007	 	 	 	36	 
	WEBMD
	 	New Zealand	 	Registered	 	 	612977	 	 	 	4/20/2007	 	 	 	41	 
	WEBMD
	 	New Zealand	 	Registered	 	 	612974	 	 	 	4/20/2007	 	 	 	35	 
	WEBMD
	 	Nicaragua	 	Registered	 	 	43,560 C.C.	 	 	 	4/2/2010	 	 	 	42	 
	WEBMD
	 	Norway	 	Registered	 	 	201140	 	 	 	1/21/2010	 	 	 	42	 
	WEBMD
	 	Oman	 	Registered	 	 	20283	 	 	 	6/2/2009	 	 	 	38	 
	WEBMD
	 	Panama	 	Registered	 	 	100984	 	 	 	6/4/2009	 	 	 	42	 
	WEBMD
	 	Paraguay	 	Registered	 	 	226.858	 	 	 	7/20/2010	 	 	 	42	 
	WEBMD
	 	Peru	 	Registered	 	 	19250	 	 	 	10/27/2009	 	 	 	38	 
	WEBMD
	 	Portugal	 	Registered	 	 	337541	 	 	 	12/20/2009	 	 	 	42	 
	WEBMD
	 	Romania	 	Registered	 	 	39027	 	 	 	6/3/2009	 	 	 	42	 
	WEBMD
	 	Russian Fed.	 	Registered	 	 	220083	 	 	 	6/1/2009	 	 	 	42	 
	WEBMD
	 	Saudi Arabia	 	Registered	 	 	589/85	 	 	 	2/16/2009	 	 	 	42	 
	WEBMD
	 	Singapore	 	Registered	 	 	T99/05709H	 	 	 	12/7/2008	 	 	 	42	 
	WEBMD
	 	Slovenia	 	Registered	 	 	9970679	 	 	 	5/31/2009	 	 	 	42	 
	WEBMD
	 	South Africa	 	Registered	 	 	99/09677	 	 	 	5/31/2009	 	 	 	42	 
	WEBMD
	 	South Korea	 	Registered	 	 	63096	 	 	 	8/24/2010	 	 	 	42	 
	WEBMD
	 	Spain	 	Registered	 	 	2239017	 	 	 	6/4/2009	 	 	 	42	 
	WEBMD
	 	Sweden	 	Registered	 	 	351648	 	 	 	1/18/2012	 	 	 	36, 38, 41, 42	 
	WEBMD
	 	Switzerland	 	Registered	 	 	469.131	 	 	 	5/31/2009	 	 	 	42	 
	WEBMD
	 	Taiwan	 	Registered	 	 	146094	 	 	 	7/15/2011	 	 	 	42	 
	WEBMD
	 	Turkey	 	Registered	 	 	99/07785	 	 	 	5/31/2009	 	 	 	41	 
	WEBMD
	 	U.A.E.	 	Registered	 	 	24645	 	 	 	8/14/2009	 	 	 	38	 
	WEBMD
	 	United Kingdom	 	Registered	 	 	2199374	 	 	 	6/7/2009	 	 	 	42	 
	WEBMD
	 	US	 	Registered	 	 	2,394,818	 	 	 	10/17/2010	 	 	 	35, 36, 38, 41, 42	 
	WEBMD
	 	Uruguay	 	Registered	 	 	313.395	 	 	 	3/24/2010	 	 	 	38	 
	WEBMD
	 	Venezuela	 	Registered	 	 	13320-S	 	 	 	7/7/2010	 	 	 	42	 
	WEB-MD
	 	US	 	Registered	 	 	2,349,285	 	 	 	5/16/2010	 	 	 	42	 
	WEBMD PRACTICE
	 	US	 	Registered	 	 	2,569,050	 	 	 	5/14/2012	 	 	 	9, 42	 
	WEDMD ONCALL
	 	US	 	Registered	 	 	2,508,413	 	 	 	11/20/2011	 	 	 	35

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00090-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00090-of-00352.parquet"}]]